I could not get the full article as you have to be a 'health professional' to get access
What is interesting is that only 9 months ago, one of the same researchers published the outcome that NCGI could exist. (excerpt below)AGW 2011, Brisbane: Initiation of a gluten free diet (GFD) without adequate exclusion of coeliac disease is “alarmingly” high, research suggests. “The importance of excluding coeliac disease cannot be underplayed,” Ms Jessica Biesiekierski from Monash University told the audience. Ms Biesiekierski previously led research co-authored by Professor Peter Gibson, proving the existence of non-coeliac gluten intolerance. The new study of about 130 patients who believed they had non-coeliac gluten intolerance (NCGI) found only 29% met the description for NCGI.
To go from 'could exist' and 9 months later say 29% of people in the study did have NCGI is a noteable development.....
admittedly their study was to prove that people think they are gluten intolerant may not be - so hence the 29% result, going forward, for the Gastro specialists to start acknowledging that NCGI exists is a milestone
(one small step for GI's, one giant leap for NCGI patients!!!!)
Am J Gastroenterol. 2011 Mar;106(3):508-14; quiz 515. Epub 2011 Jan 11.
Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial.
Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD, Shepherd SJ, Muir JG, Gibson PR.
SourceMonash University Department of Medicine and Gastroenterology, Box Hill Hospital, Box Hill, Victoria, Australia.
Abstract
OBJECTIVES: Despite increased prescription of a gluten-free diet for gastrointestinal symptoms in individuals who do not have celiac disease, there is minimal evidence that suggests that gluten is a trigger. The aims of this study were to determine whether gluten ingestion can induce symptoms in non-celiac individuals and to examine the mechanism.
METHODS: A double-blind, randomized, placebo-controlled rechallenge trial was undertaken in patients with irritable bowel syndrome in whom celiac disease was excluded and who were symptomatically controlled on a gluten-free diet. Participants received either gluten or placebo in the form of two bread slices plus one muffin per day with a gluten-free diet for up to 6 weeks. Symptoms were evaluated using a visual analog scale and markers of intestinal inflammation, injury, and immune activation were monitored.
RESULTS: A total of 34 patients (aged 29-59 years, 4 men) completed the study as per protocol. Overall, 56% had human leukocyte antigen (HLA)-DQ2 and/or HLA-DQ8. Adherence to diet and supplements was very high. Of 19 patients (68%) in the gluten group, 13 reported that symptoms were not adequately controlled compared with 6 of 15 (40%) on placebo (P=0.0001; generalized estimating equation). On a visual analog scale, patients were significantly worse with gluten within 1 week for overall symptoms (P=0.047), pain (P=0.016), bloating (P=0.031), satisfaction with stool consistency (P=0.024), and tiredness (P=0.001). Anti-gliadin antibodies were not induced. There were no significant changes in fecal lactoferrin, levels of celiac antibodies, highly sensitive C-reactive protein, or intestinal permeability. There were no differences in any end point in individuals with or without DQ2/DQ8.
CONCLUSIONS: "Non-celiac gluten intolerance" may exist, but no clues to the mechanism were elucidated

Visit the Microscopic Colitis Foundation Website





